FDA
approval
· 2020-02-21
FDA Approved: SODIUM POLYSTYRENE SULFONATE — Supplemental Application (SUNRISE PHARMACEUTICAL, INC.)
Summary
FDA approved a supplemental application for Sodium Polystyrene Sulfonate from Sunrise Pharmaceutical, Inc., resulting in an approved generic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SODIUM POLYSTYRENE SULFONATE (SODIUM POLYSTYRENE SULFONATE)